استفاده از لام کوت شده تیموس گوساله جهت تشخیص آنتی‌بادی ضدهسته در سرم بیماران مبتلا‌به بیماری لوپوس

Sekigawa I, Yamada M, Iida N, Hashimoto H, Ogawa H. Comparison of serum IgE levels between female and male SLE patients, with reference to gender differences in the incidence of SLE. Clin Exp Rheumatol 2004;22:384-5.

Hang L, Izui S, Theofilopoulos AN, Dixon FJ. Suppression of transferred BXSB male SLE disease by female spleen cells. J Immunol 1982;128:1805-8.

Buccini RV. Childhood SLE--male:female ratio. Hosp Pract 1979;14:21-2.

Skeoch S, Haque S, Pemberton P, Bruce IN. Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLE. Lupus 2014;23:819-24. doi: 10.1177/0961203314528061

Pizarro S, Monarrez Espino J, Ruiz A, Jara LJ, Nava A, Riebeling-Navarro C. Soluble vascular cell adhesion molecule-1 indicates SLE disease activity and specific organ involvement. Rev Alerg Mex 2007;54:189-95.

Tas SW, Quartier P, Botto M, Fossati-Jimack L. Macrophages from patients with SLE and rheumatoid arthritis have defective adhesion in vitro, while only SLE macrophages have impaired uptake of apoptotic cells. Ann Rheum Dis 2006;65:216-21. doi: 10.1136/ard .2005.037143

Avery TY, van de Cruys M, Austen J, Stals F, Damoiseaux JG. Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care. Journal of Immunology Research 2014;2014:401739. doi: 10.1155/2014/401739

Shin JI, Kim KH, Chun JK, Lee TJ, Kim KJ, Kim HS, et al. Prevalence and patterns of anti-nuclear antibodies in Korean children with juvenile idiopathic arthritis according to ILAR criteria. Scandinavian Journal of Rheumatology 2008;37:348-51. doi: 10.1080/03009740801998762

Hansen BU, Eriksson S, Lindgren S. High prevalence of autoimmune liver disease in patients with multiple nuclear dot, anti-centromere, and mitotic spindle antibodies. Scandinavian Journal of Gastroenterology 1991;26:707-13. doi: 10.3109/003655291089985 88

Grennan DM, Parfitt A, Manolios N, Huang Q, Hyland V, Dunckley H, et al. Family and twin studies in systemic lupus erythematosus. Dis Markers 1997;13:93-8.

Agnello V. Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. Arthritis and Rheumatism 1978;21:S146-52. doi: 10.1002/art. 1780210923

Kozora E, Ellison MC, West S. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Arthritis and Rheumatism 2006;55:628-35. doi: 10.1002/art.22101

Condemi JJ. SLE: idiopathic or drug-induced? Geriatrics 1980;35:81-8.

Gastineau DA, Holcomb GR. Lupus anticoagulant in drug-induced systemic lupus erythematosus (SLE). Arch Intern Med 1985;145:1926-7.

Schattner A, Sthoeger Z, Geltner D. Effect of acute cytomegalovirus infection on drug-induced SLE. Postgrad Med J 1994;70:738-40. doi: 10.1136/pgmj.70.828.738

Cowchock S, Fort JG. Can tests for IgA, IgG, or IgM antibodies to cardiolipin or phosphatidylserine substitute for lupus anticoagulant assays in screening for antiphospholipid antibodies? Autoimmunity 1994;17:119-22. doi: 10.3109/08916939409014666

Dhaher YY, Chan K, Greenstein BD, de Fougerolles Nunn E, Khamashta MA, Hughes GR. Impaired estrogen priming of progesterone receptors in uterus of MRL/MP-lpr/lpr mice, a model of systemic lupus erythematosus (SLE). International Journal of Immunopharmacology 2000;22:537-45. doi: 10.1016/S0192-0561 (00)00017-5

Ghosh K, Patwardhan M, Pradhan V. Mycobacterium tuberculosis infection precipitates SLE in patients from endemic areas. Rheumatology International 2009;29:1047-50. doi: 10.1007/s00296-009-0903-x

Jiang B, Sun L, Hao S, Li X, Xu Y, Hou Y. Estrogen modulates bone marrow-derived DCs in SLE murine model-(NZB x NZW) F1 female mice. Immunological Investigations 2008;37:227-43. doi: 10.1080/08820130801973328

Kim JM, Son CN, Chang HW, Kim SH. Simultaneous presentation of acute disseminated encephalomyelitis (ADEM) and systemic lupus erythematosus (SLE) after enteroviral infection: can ADEM present as the first manifestation of SLE? Lupus 2015;24:633-7. doi: 10.1177/0961203314560426

McAlindon TE, Gulin J, Chen T, Klug T, Lahita R, Nuite M. Indole-3-carbinol in women with SLE: effect on estrogen metabolism and disease activity. Lupus 2001;10:779-83. doi: 10.1177/096120330101001104

Ochi S, Kato S, Nakamura-Uchiyama F, Ohnishi K, Saito Y. Pseudo-SLE by human immunodeficiency virus infection. Modern rheumatology / the Japan Rheumatism Association.1-3. doi: 10.3109/14397595.2014.997822

Saravana S, James DW, Abourawi F, Gupta PC, Samyukta B. HIV infection mimicking SLE. Clinical Rheumatology 2004;23:562-3. doi: 10.1007/s10067-004-0938-z

Jearn LH, Kim DA, Kim TY. Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus. The Journal of Rheumatology 2009;36:1833-4. doi: 10.3899/jrheum.090118

Perl A, Gonzalez-Cabello R, Lang I, Gergely P. Depressed natural and lectin-dependent cell-mediated cytotoxicity against adherent HEp-2 cells in patients with systemic lupus erythematosus. Immunological Communications 1982;11:431-40. doi: 10.3109/0882 0138209050740

Divate S, Hardikar P, Bichile L, Rajadhyaksha A. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay—a preliminary study. J Assoc Physicians India 2004;52:290-3.

Greidinger EL, Hoffman RW. Antinuclear antibody testing: Methods, indications, and interpretation. Laboratory Medicine 2003;34:113-7. doi: 10.1309/VUB90VTPMEWV3W0F

Gniewek RA, Stites DP, Mchugh TM, Hilton JF, Nakagawa M. Comparison of antinuclear antibody testing methods: immunofluorescence assay versus enzyme immunoassay. Clin Diagn Lab Immunol 1997;4:185-8.

Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. American Journal of Clinical Pathology 2002;117:316-24. doi: 10.1309/Y5VF-C3DM-L8XV-U053

Meroni PL, Schur PH. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010;69:1420-2. doi: 10.1136/ ard.2009.127100

Angel J, Thomas M, Appalaraju B. Evaluation of ELISA and indirect immunofluorescence in the diagnosis of autoimmune diseases and their interpretation in the clinical situation. Journal of The Academy of Clinical Microbiologists 2015;17:7-11. doi: 10.410 3/0972-1282.158776

Jacobsen EM, Wisloff F. False negative screening tests for lupus anticoagulants--an unrecognized problem? Thrombosis Research 1996;82:445-51. doi: 10.1016/0049-3848(96)00094-1

Forastiero RR, Falcon CR, Carreras LO. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant. Haemostasis 1990;20:208-14. doi: 10.1159/0002161 29

Follea G, Ffrench P, Trzeciak MC, Dechavanne M. [Lupus anticoagulant screening: comparison of 5 tests (author's transl)]. Nouv Rev Fr Hematologie 1981;23:203-7.